193 related articles for article (PubMed ID: 36315912)
1. Noncanonical β-catenin interactions promote leukemia-initiating activity in early T-cell acute lymphoblastic leukemia.
Panelli P; De Santis E; Colucci M; Tamiro F; Sansico F; Miroballo M; Murgo E; Padovano C; Gusscott S; Ciavarella M; Chavez EA; Bianchi F; Rossi G; Carella AM; Steidl C; Weng AP; Giambra V
Blood; 2023 Mar; 141(13):1597-1609. PubMed ID: 36315912
[TBL] [Abstract][Full Text] [Related]
2. Leukemia stem cells in T-ALL require active Hif1α and Wnt signaling.
Giambra V; Jenkins CE; Lam SH; Hoofd C; Belmonte M; Wang X; Gusscott S; Gracias D; Weng AP
Blood; 2015 Jun; 125(25):3917-27. PubMed ID: 25934477
[TBL] [Abstract][Full Text] [Related]
3. JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/β-catenin/CCND1 signaling.
Zhang Y; Xia F; Liu X; Yu Z; Xie L; Liu L; Chen C; Jiang H; Hao X; He X; Zhang F; Gu H; Zhu J; Bai H; Zhang CC; Chen GQ; Zheng J
J Clin Invest; 2018 May; 128(5):1737-1751. PubMed ID: 29584620
[TBL] [Abstract][Full Text] [Related]
4. Revisiting β-Catenin Signaling in T-Cell Development and T-Cell Acute Lymphoblastic Leukemia.
Bigas A; Guillén Y; Schoch L; Arambilet D
Bioessays; 2020 Feb; 42(2):e1900099. PubMed ID: 31854474
[TBL] [Abstract][Full Text] [Related]
5. The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia.
Murgo E; De Santis E; Sansico F; Melocchi V; Colangelo T; Padovano C; Colucci M; Carbone A; Totti B; Basti A; Gottschlich L; Relogio A; Capitanio N; Bianchi F; Mazzoccoli G; Giambra V
J Exp Clin Cancer Res; 2023 Aug; 42(1):218. PubMed ID: 37620852
[TBL] [Abstract][Full Text] [Related]
6. Targeting Leukemia-Initiating Cells in Acute Lymphoblastic Leukemia.
Tamiro F; Weng AP; Giambra V
Cancer Res; 2021 Aug; 81(16):4165-4173. PubMed ID: 33414170
[TBL] [Abstract][Full Text] [Related]
7. NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-θ and reactive oxygen species.
Giambra V; Jenkins CR; Wang H; Lam SH; Shevchuk OO; Nemirovsky O; Wai C; Gusscott S; Chiang MY; Aster JC; Humphries RK; Eaves C; Weng AP
Nat Med; 2012 Nov; 18(11):1693-8. PubMed ID: 23086478
[TBL] [Abstract][Full Text] [Related]
8. Notch1 gene mutations target KRAS G12D-expressing CD8+ cells and contribute to their leukemogenic transformation.
Kong G; Du J; Liu Y; Meline B; Chang YI; Ranheim EA; Wang J; Zhang J
J Biol Chem; 2013 Jun; 288(25):18219-27. PubMed ID: 23673656
[TBL] [Abstract][Full Text] [Related]
9. Miltefosine suppression of Pten null T-ALL leukemia via β-catenin degradation through inhibition of pT308-Akt and TGFβ1/Smad3.
Zhang Y; Lee S; Xu W
Biochem Biophys Res Commun; 2020 Apr; 524(4):1018-1024. PubMed ID: 32063363
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations.
Gerby B; Clappier E; Armstrong F; Deswarte C; Calvo J; Poglio S; Soulier J; Boissel N; Leblanc T; Baruchel A; Landman-Parker J; Roméo PH; Ballerini P; Pflumio F
Leukemia; 2011 Aug; 25(8):1249-58. PubMed ID: 21566655
[TBL] [Abstract][Full Text] [Related]
11. β-Catenin and its new partner FOXO3 shake T-ALL.
Calvo J; Pflumio F
Blood; 2023 Mar; 141(13):1503-1505. PubMed ID: 36995702
[No Abstract] [Full Text] [Related]
12. A functional role of Ephrin type-B receptor 6 (EPHB6) in T-cell acute lymphoblastic leukemia.
Colucci M; Trivieri N; Mencarelli G; De Santis E; Sansico F; Tamiro F; Visioli A; Barile C; Pracella R; Rossi G; Binda E; Giambra V
Biomark Res; 2023 Oct; 11(1):92. PubMed ID: 37858274
[TBL] [Abstract][Full Text] [Related]
13. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
[TBL] [Abstract][Full Text] [Related]
14. IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.
González-García S; Mosquera M; Fuentes P; Palumbo T; Escudero A; Pérez-Martínez A; Ramírez M; Corcoran AE; Toribio ML
Blood; 2019 Dec; 134(24):2171-2182. PubMed ID: 31530562
[TBL] [Abstract][Full Text] [Related]
15. NOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive niches.
Ma W; Gutierrez A; Goff DJ; Geron I; Sadarangani A; Jamieson CA; Court AC; Shih AY; Jiang Q; Wu CC; Li K; Smith KM; Crews LA; Gibson NW; Deichaite I; Morris SR; Wei P; Carson DA; Look AT; Jamieson CH
PLoS One; 2012; 7(6):e39725. PubMed ID: 22768113
[TBL] [Abstract][Full Text] [Related]
16. CD82 supports survival of childhood acute myeloid leukemia cells via activation of Wnt/β-catenin signaling pathway.
Ji H; Chen L; Xing Y; Li S; Dai J; Zhao P; Wang Y
Pediatr Res; 2019 Jun; 85(7):1024-1031. PubMed ID: 30862962
[TBL] [Abstract][Full Text] [Related]
17. JS-K, a nitric oxide-releasing prodrug, modulates ß-catenin/TCF signaling in leukemic Jurkat cells: evidence of an S-nitrosylated mechanism.
Nath N; Chattopadhyay M; Pospishil L; Cieciura LZ; Goswami S; Kodela R; Saavedra JE; Keefer LK; Kashfi K
Biochem Pharmacol; 2010 Dec; 80(11):1641-9. PubMed ID: 20797387
[TBL] [Abstract][Full Text] [Related]
18. Targeting the MYC and PI3K pathways eliminates leukemia-initiating cells in T-cell acute lymphoblastic leukemia.
Schubbert S; Cardenas A; Chen H; Garcia C; Guo W; Bradner J; Wu H
Cancer Res; 2014 Dec; 74(23):7048-59. PubMed ID: 25287161
[TBL] [Abstract][Full Text] [Related]
19. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia.
Evangelisti C; Chiarini F; Cappellini A; Paganelli F; Fini M; Santi S; Martelli AM; Neri LM; Evangelisti C
J Cell Physiol; 2020 Jun; 235(6):5413-5428. PubMed ID: 31904116
[TBL] [Abstract][Full Text] [Related]
20. β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia.
García-Hernández V; Arambilet D; Guillén Y; Lobo-Jarne T; Maqueda M; Gekas C; González J; Iglesias A; Vega-García N; Sentís I; Trincado JL; Márquez-López I; Heyn H; Camós M; Espinosa L; Bigas A
EMBO Mol Med; 2023 Feb; 15(2):e16554. PubMed ID: 36597789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
